Medicenna Therapeutics Corp (MDNA:CA) Annual Income Statement (CAD)
MDNA:CA Quarterly Financials (CAD)
Frequently Asked Questions About Medicenna Therapeutics Corp (MDNA:CA) Stock
Medicenna Therapeutics Corp's (MDNA:CA) last reported annual revenue was CAD 0.00.
Medicenna Therapeutics Corp's (MDNA:CA) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Medicenna Therapeutics Corp's(MDNA:CA) is not profitable as of its last reported annual financials.
The net profit margin for Medicenna Therapeutics Corp's(MDNA:CA) from its laster reported year is N/A
The return on equity (ROE) for Medicenna Therapeutics Corp's(MDNA:CA) from its last reported annual financials is : -59.47%
The return on assets (ROA) for Medicenna Therapeutics Corp's(MDNA:CA) from its last reported annual financials is : -34.57%
The return on invested capital (ROIC) for Medicenna Therapeutics Corp's(MDNA:CA) from its last reported annual financials is : -64.80%
The Debt to Equity ratio for Medicenna Therapeutics Corp's(MDNA:CA) from its last reported annual financials is : 0.00%
The dividend yield for Medicenna Therapeutics Corp's(MDNA:CA) from its laster reported year is 0.00%
Medicenna Therapeutics Corp's(MDNA:CA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MDNA:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
